[Intracavernous pharmacotherapy in men who have undergone cystectomy for neoplasia].
Impotentia erigendi is a consequence of radical surgery such as cystectomy due to neoplasia. It is caused by damage to neurovascular structures, and in particular to the nerve fibres of the sacral plexus. Current therapies include the use of penile prostheses or drug therapy. The paper reports the Authors' personal experience of the use of intracavernous drug therapy in 24 patients cystectomised due to vesical carcinoma. Objectively valid results were obtained in 33% of patients. No complications were observed and the treatment represents a valid alternative to mechanical prosthesis.
Cocimano
V
V
Divisione di Urologia, Ospedale Mauriziano, Torino.
Marino
G
G
Pastorini
S
S
Brigato
R
R
Cevoli
R
R
Griffa
D
D
D000368:Aged; D015653:Cystectomy / Q000009:adverse effects*; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007267:Injections; D008160:Lumbosacral Plexus / Q000293:injuries; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage / Q000627:therapeutic use*; D010413:Penis; D001749:Urinary Bladder Neoplasms / Q000150:complications / Q000601:surgery*
D010208:Papaverine
Farmacoterapia intracavernosa nei cistectomizzati per neoplasia.